James C. Blair is 10% at Orexigen Therapeutics, Inc. (OREX). They have made 52 open-market trades across 19 companies since 2006, most recently 2019-08-20.
CIK 0001024000
30 open-market purchases totalling $131.2M since 2006, against 22 sales. Across 7 scored buys the stock is down 4.7% at ninety days, and 4.7 points behind the S&P over the same stretch.
7 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 0% | 0% | 14% |
| Avg Move | -24.7% | -9.7% | -4.7% |
| Alpha | -20.6% | -10.3% | -4.7% |
| Scored | 7 | 7 | 7 |
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 83% | 67% | 67% |
| Avg Move | -12.7% | +1.4% | -5.1% |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CLVS | BUY | 2019-08-16 | 2019-08-20 | $5.84 | $233K | -8.3% | -20.4% | +15.4% |
| CLVS | SELL | 2019-03-14 | 2019-03-18 | $27.79 | $474K | -11.1% | -24.1% | -48.5% |
| CLVS | SELL | 2019-03-14 | 2019-03-18 | $27.79 | $474K | -11.1% | -24.1% | -48.5% |
| BNGO | BUY | 2018-08-23 | 2018-08-27 | $6.13 | $92K | -23.7% | -34.7% | -35.0% |
| CLVS | SELL | 2017-08-04 | 2017-08-08 | $78.61 | $2.9M | -3.9% | -3.4% | -3.3% |
| EVOK | SELL | 2016-05-26 | 2016-05-27 | $4.70 | $1.6M | -2.8% | +14.9% | -63.9% |
| EVOK | SELL | 2016-04-06 | 2016-04-08 | $5.28 | $5K | +1.2% | -2.3% | +37.4% |
| EVOK | SELL | 2015-04-14 | 2015-04-16 | $7.29 | $6K | -20.8% | -0.3% | -0.3% |
| CLVS | SELL | 2015-03-05 | 2015-03-05 | $77.70 | $663K | -29.4% | -2.5% | -2.5% |
| NEOT | BUY | 2014-11-25 | 2014-11-26 | $14.00 | $980K | N/A | N/A | N/A |
| RGDO | BUY | 2013-08-27 | 2013-08-28 | $4.00 | $3.0M | N/A | N/A | N/A |
| OCRX | BUY | 2013-07-15 | 2013-07-31 | $6.03 | $8.0M | N/A | N/A | N/A |
| ESPR | BUY | 2013-07-01 | 2013-07-02 | $14.00 | $4.0M | -35.3% | -0.8% | -0.8% |
| ALIM | SELL · 10b5-1 | 2013-06-14 | 2013-06-18 | $5.29 | $7K | -20.2% | +0.0% | +0.0% |
| CLVS | SELL | 2013-03-04 | 2013-03-06 | $24.59 | $103K | -29.4% | -2.5% | -2.5% |
| CADX | SELL · 10b5-1 | 2013-02-20 | 2013-02-22 | $5.01 | $170 | N/A | N/A | N/A |
| CADX | SELL · 10b5-1 | 2013-02-20 | 2013-02-22 | $5.01 | $331 | N/A | N/A | N/A |
| CADX | SELL · 10b5-1 | 2013-02-20 | 2013-02-22 | $5.01 | $10K | N/A | N/A | N/A |
| CADX | SELL · 10b5-1 | 2013-02-15 | 2013-02-20 | $5.02 | $2K | N/A | N/A | N/A |
| CADX | SELL · 10b5-1 | 2013-02-13 | 2013-02-15 | $5.00 | $746 | N/A | N/A | N/A |
| CADX | SELL · 10b5-1 | 2013-02-01 | 2013-02-05 | $4.85 | $2K | N/A | N/A | N/A |
| CADX | SELL · 10b5-1 | 2013-01-30 | 2013-02-01 | $4.82 | $5K | N/A | N/A | N/A |
| CADX | SELL · 10b5-1 | 2013-01-17 | 2013-01-22 | $5.25 | $167K | N/A | N/A | N/A |
| DRTX | BUY | 2012-07-24 | 2012-07-24 | $9.00 | $7.1M | N/A | N/A | N/A |
| RVA | SELL | 2012-03-23 | 2012-03-27 | $5.16 | $8.7M | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| TNDM | 54,390 | $883K |
| ALIM | 38,864 | $215K |
| SNDX | 13,925 | $180K |
| NUVA | 3,457 | $137K |
| ESPR | 35,253 | $112K |
| VNDA | 20,458 | $83K |
| MRNS | 17,000 | $9K |
| AKAO | 33,890 | $4K |
| CLVS | 33,439 | $3K |
| OTIC | 11,715 | $902 |
| OCRX | 1,857,036 | — |
| OREX | 2,967,415 | — |
| PHRM | 1,342,220 | — |
| RGDO | 2,571,117 | — |
| RVA | 3,606,002 | — |
| SENO | 24,665 | — |
| NEOT | 3,122,774 | — |
| SOMX | 1,714,789 | — |
| IOMI | 40,153 | — |
| CADX | 50,743 | — |
| VOLC | 62,513 | — |
| NSTR | 2,068,500 | — |
| DRTX | 3,006,132 | — |
| NOVC | 67,875 | — |
| Total | $552.9M |
Shares reported on the most recent Form 4, priced at the 2019-08-20 close. 14 holdings could not be priced and are excluded from the total.
| Scored | 6 | 6 | 6 |